SmartPharma Group, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
372,814 |
255,352 |
22,583 |
19,191 |
13,145 |
9.02 |
5.15 |
43,541 |
32,142 |
1,487 |
74,196 |
2023 |
---|
446,037 |
437,291 |
26,112 |
22,195 |
21,760 |
17.25 |
4.98 |
65,736 |
222,515 |
29,388 |
258,588 |
2024 |
---|
858,736 |
727,742 |
321,651 |
273,400 |
231,695 |
42.52 |
31.84 |
339,136 |
82,909 |
273,657 |
148,388 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
858,736 €93 % *
Sales per employee (€)
727,742 €66 % *
Profit before tax (€)
321,651 €1,132 % *
Net Profit (€)
273,400 €1,132 % *
Profit per employee (€)
231,695 €965 % *
Total profitability (%)
42.52 %146.49 % *
Net profitability (%)
31.84 %539.36 % *
Equity (€)
339,136 €416 % *
Amounts Payable And Liabilities (€)
82,909 €-63 % *
Non-current Assets (€)
273,657 €831 % *
CurrentAssets (€)
148,388 €-43 % *